KCNT1 inhibitors are chemical compounds that target the KCNT1 gene, which encodes a sodium-activated potassium channel (KNa). This channel plays a critical role in regulating neuronal excitability by allowing potassium ions to flow out of the cell in response to sodium levels, thereby influencing membrane potential and neural firing. These inhibitors act by blocking or modulating the activity of the KCNT1 channel, reducing potassium ion flux, and affecting the electrical signaling within neurons. Since potassium channels are integral to maintaining ion homeostasis and cellular functions, inhibitors of KCNT1 can alter neuronal activity, potentially affecting the overall excitability of the nervous system.
KCNT1 inhibitors can vary in their chemical structure and mode of action, but their primary focus is on modulating the potassium ion conductance across the cellular membrane. By interfering with the channel's function, these inhibitors may alter the dynamics of ion exchange, leading to changes in cellular electrophysiology. The specificity of these inhibitors for the KCNT1 channel is crucial, as potassium channels are ubiquitous in many types of cells and tissues. Consequently, the development and identification of KCNT1 inhibitors often involve structural analysis of the channel's binding sites, as well as considerations of the inhibitor's affinity and efficacy in blocking the channel's ion conductance. Understanding the intricate mechanisms by which these inhibitors interact with the KCNT1 channel provides valuable insights into the regulation of ion channels at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
A known inhibitor of voltage-gated potassium channels, quinidine can indirectly affect the function of KCNT1 by modifying the overall potassium ion flux and membrane potential. | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $437.00 $1040.00 | 1 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that can affect a variety of ion channels indirectly by altering intracellular signaling pathways. | ||||||
Iberiotoxin | 129203-60-7 | sc-3585 sc-3585A | 10 µg 100 µg | $275.00 $500.00 | 16 | |
A selective blocker of large conductance Ca2+-activated K+ channels, which can influence the overall potassium current and indirectly impact KCNT1 function. | ||||||
Charybdotoxin | 95751-30-7 | sc-200979 | 100 µg | $401.00 | 9 | |
A blocker of intermediate-conductance Ca2+-activated K+ channels, which can indirectly affect KCNT1 by changing the electrochemical gradient. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
A metal ion that can modulate the function of a wide range of ion channels, including KCNT1, by altering their gating properties. | ||||||
Amiodarone | 1951-25-3 | sc-480089 | 5 g | $318.00 | ||
An antiarrhythmic agent that can modulate the function of multiple ion channels, potentially affecting KCNT1 indirectly through changes in membrane excitability. | ||||||